vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and LandBridge Co LLC (LB). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $51.0M, roughly 2.0× LandBridge Co LLC). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 16.0%). LandBridge Co LLC produced more free cash flow last quarter ($40.9M vs $-35.5M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (40.2% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

IMCR vs LB — Head-to-Head

Bigger by revenue
IMCR
IMCR
2.0× larger
IMCR
$104.5M
$51.0M
LB
Growing faster (revenue YoY)
IMCR
IMCR
+8.3% gap
IMCR
24.3%
16.0%
LB
More free cash flow
LB
LB
$76.5M more FCF
LB
$40.9M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
40.2%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IMCR
IMCR
LB
LB
Revenue
$104.5M
$51.0M
Net Profit
$17.9M
Gross Margin
97.4%
Operating Margin
-18.8%
57.2%
Net Margin
35.0%
Revenue YoY
24.3%
16.0%
Net Profit YoY
15.6%
EPS (diluted)
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
LB
LB
Q1 26
$51.0M
Q4 25
$104.5M
$56.8M
Q3 25
$103.7M
$50.8M
Q2 25
$98.0M
$47.5M
Q1 25
$93.9M
$44.0M
Q4 24
$84.1M
$36.5M
Q3 24
$80.2M
$28.5M
Q2 24
$75.4M
$26.0M
Net Profit
IMCR
IMCR
LB
LB
Q1 26
$17.9M
Q4 25
$8.1M
Q3 25
$-177.0K
$8.1M
Q2 25
$-10.3M
$7.5M
Q1 25
$5.0M
$6.5M
Q4 24
$49.3M
Q3 24
$8.7M
$2.7M
Q2 24
$-11.6M
$-57.7M
Gross Margin
IMCR
IMCR
LB
LB
Q1 26
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Operating Margin
IMCR
IMCR
LB
LB
Q1 26
57.2%
Q4 25
-18.8%
60.0%
Q3 25
-6.9%
60.8%
Q2 25
-15.2%
60.0%
Q1 25
-3.9%
57.0%
Q4 24
-23.1%
49.4%
Q3 24
-10.6%
11.2%
Q2 24
-21.2%
-197.4%
Net Margin
IMCR
IMCR
LB
LB
Q1 26
35.0%
Q4 25
14.2%
Q3 25
-0.2%
15.9%
Q2 25
-10.5%
15.8%
Q1 25
5.4%
14.7%
Q4 24
135.2%
Q3 24
10.9%
9.3%
Q2 24
-15.4%
-222.1%
EPS (diluted)
IMCR
IMCR
LB
LB
Q1 26
Q4 25
$-0.61
$0.24
Q3 25
$0.00
$0.26
Q2 25
$-0.20
$0.24
Q1 25
$0.10
$0.20
Q4 24
$-0.47
Q3 24
$0.17
$-0.04
Q2 24
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
LB
LB
Cash + ST InvestmentsLiquidity on hand
$864.2M
$29.7M
Total DebtLower is stronger
$433.0K
Stockholders' EquityBook value
$381.0M
Total Assets
$1.1B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
LB
LB
Q1 26
$29.7M
Q4 25
$864.2M
$30.7M
Q3 25
$892.4M
$28.3M
Q2 25
$882.8M
$20.3M
Q1 25
$837.0M
$14.9M
Q4 24
$820.4M
$37.0M
Q3 24
$901.3M
$14.4M
Q2 24
$859.6M
$24.6M
Total Debt
IMCR
IMCR
LB
LB
Q1 26
$433.0K
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$438.7M
$242.4M
Q2 24
$452.5M
$360.8M
Stockholders' Equity
IMCR
IMCR
LB
LB
Q1 26
Q4 25
$381.0M
$340.3M
Q3 25
$396.6M
$272.0M
Q2 25
$388.5M
$266.4M
Q1 25
$378.5M
$217.0M
Q4 24
$360.7M
$211.8M
Q3 24
$377.8M
$97.2M
Q2 24
$359.1M
$296.4M
Total Assets
IMCR
IMCR
LB
LB
Q1 26
$1.4B
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.1B
Q2 25
$1.1B
$1.1B
Q1 25
$1.0B
$1.0B
Q4 24
$1.0B
$1.0B
Q3 24
$1.1B
$689.9M
Q2 24
$1.0B
$710.5M
Debt / Equity
IMCR
IMCR
LB
LB
Q1 26
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
1.16×
2.49×
Q2 24
1.26×
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
LB
LB
Operating Cash FlowLast quarter
$-32.7M
$41.1M
Free Cash FlowOCF − Capex
$-35.5M
$40.9M
FCF MarginFCF / Revenue
-34.0%
80.3%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$232.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
LB
LB
Q1 26
$41.1M
Q4 25
$-32.7M
$126.3M
Q3 25
$-4.5M
$34.9M
Q2 25
$26.0M
$37.3M
Q1 25
$435.0K
$15.9M
Q4 24
$-14.0M
$67.6M
Q3 24
$21.1M
$7.5M
Q2 24
$23.5M
$16.0M
Free Cash Flow
IMCR
IMCR
LB
LB
Q1 26
$40.9M
Q4 25
$-35.5M
$122.0M
Q3 25
$-5.2M
$33.7M
Q2 25
$25.6M
$36.1M
Q1 25
$137.0K
$15.8M
Q4 24
$-17.5M
$66.7M
Q3 24
$20.3M
$7.1M
Q2 24
$23.1M
$15.7M
FCF Margin
IMCR
IMCR
LB
LB
Q1 26
80.3%
Q4 25
-34.0%
214.9%
Q3 25
-5.0%
66.3%
Q2 25
26.1%
75.9%
Q1 25
0.1%
36.0%
Q4 24
-20.9%
182.6%
Q3 24
25.3%
25.1%
Q2 24
30.7%
60.4%
Capex Intensity
IMCR
IMCR
LB
LB
Q1 26
Q4 25
2.8%
7.5%
Q3 25
0.7%
2.3%
Q2 25
0.4%
2.6%
Q1 25
0.3%
0.2%
Q4 24
4.3%
2.7%
Q3 24
1.0%
1.1%
Q2 24
0.4%
1.4%
Cash Conversion
IMCR
IMCR
LB
LB
Q1 26
2.30×
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
0.09×
2.46×
Q4 24
1.37×
Q3 24
2.42×
2.80×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

LB
LB

Other$14.2M28%
Easements and other surface-related revenues$11.6M23%
Surface use royalties - related party$11.0M22%
Resource sales$5.2M10%
Resource royalties$4.3M8%
Easements and other surface-related revenues - related party$3.2M6%
Resource royalties - related party$1.3M2%
Resource sales - related party$205.0K0%

Related Comparisons